RSS
27 Jul 2022

Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement

Author: admintech | Filed under: Press Release

MELBOURNE, Australia, July 27, 2022 /PRNewswire/ — Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report and appendix 4C for the period ended 30 June…

This entry was posted on Wednesday, July 27th, 2022 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»